News

AlphaBiomics wins award to validate its IBD biologic therapy response predictor RxSelex

By JLABS

Read full story

Redpin Therapeutics secures initial closing of $15.5 million in Series A financing

By JLABS

Read full story

Alumni Dragonfly Therapeutics Announces Multi-Target Expansion of its Collaboration with Merck to Use Dragonfly's Proprietary TriNKET™ Platform to Develop Novel Therapeutic Candidates in the fields of Oncology, Infectious Disease, and Immune Disorders

By JLABS

Read full story

Versatope Selects Influenza Vaccine Candidate for Clinical Development

By JLABS

Read full story

JLABS Alumni Kymera Therapeutics Announces $102 Million Series C Financing to Advance its Protein Degrader Pipeline and Platform

By JLABS

Read full story